基本信息
浏览量:0
职业迁徙
个人简介
Research Summary
We have focused on finding ways to improve transfusion safety. We have studied blood group alloimmunization, i.e. the development of antibodies to red blood cells that occurs in some patients after transfusion. These antibodies are important since they can make it difficult to find compatible blood. They also mediate destruction of transfused red blood cells and transfusion reactions. We found that these antibodies are more dangerous than previously thought due to their higher rate of disappearance over time than previously thought. Their disappearance causes them to become undetectable during transfusion compatibility testing, yet their levels increase dramatically following transfusion of incompatible red blood cells. We have also studied the tendency of some patients to develop more than one blood group antibody. Currently, we are investigating ways to better detect and prevent blood group antibodies.
We have also studied how to better prepare and store platelets for transfusion. Platelets are small blood particles that are important in the early stages of blood clotting. Some patients develop dangerously low platelet counts and require platelet transfusions to prevent bleeding. However, we have found that platelets leak substances during blood bank storage that can mediate adverse inflammatory reactions when transfused. We are attempting to understand what causes this leakage and how to prevent it.
We also have recently been investigating the use of genetic testing to better predict correct doses of anticoagulant and anti-platelet drugs. Our initial focus has been on determining the advantages and disadvantages of different testing methods.
Specialized Terms: Blood group alloimmunization; Pharmacogenetics; Blood bank storage of platelets; Pro-inflammatory cytokines; Blood transfusion
Extensive Research Description
We have investigated the role of pro-inflammatory cytokines in mediating adverse effects of blood transfusion. We have shown that leukocyte-derived cytokines such as interleukins-1, -6, - 8, as well as MIP-1 alpha, GRO-alpha, and TNF-alpha are present in the plasma portion of stored platelet concentrates and are generated in vitro during blood bank preparation and storage. Some cytokines were also detected in the supernatant portion of red blood cell units. These cytokines are generated in direct proportion to the leukocyte content of the component, the storage temperature, and the storage time. Bacterial contamination of blood components, as might occur in the setting of a septic transfusion reaction, further stimulates cytokine generation. Pre-storage leukoreduction of blood components prevents the generation of leukocyte-dereived cytokines.
Research Interests
Blood Banks; Blood Transfusion; Pathology; Pharmacogenetics; Medical Laboratory Science; Cytokines
Education & Training
Fellow
Yale-New Haven Hospital (1991)
Resident
Yale-New Haven Hospital (1990)
Fellow
Institut de Chimie Bioligique (1987)
MD
Johns Hopkins University (1984)
PhD
University of Wisconsin (1983)
BS
University of Maryland-College Park, Biochemistry (1975)
Departments & Organizations
Blood BankLaboratory MedicineLaboratory Medicine - EducationOffice of Cooperative ResearchTransfusion Medicine ProgramVA Connecticut Clinical LaboratoriesYale University
We have focused on finding ways to improve transfusion safety. We have studied blood group alloimmunization, i.e. the development of antibodies to red blood cells that occurs in some patients after transfusion. These antibodies are important since they can make it difficult to find compatible blood. They also mediate destruction of transfused red blood cells and transfusion reactions. We found that these antibodies are more dangerous than previously thought due to their higher rate of disappearance over time than previously thought. Their disappearance causes them to become undetectable during transfusion compatibility testing, yet their levels increase dramatically following transfusion of incompatible red blood cells. We have also studied the tendency of some patients to develop more than one blood group antibody. Currently, we are investigating ways to better detect and prevent blood group antibodies.
We have also studied how to better prepare and store platelets for transfusion. Platelets are small blood particles that are important in the early stages of blood clotting. Some patients develop dangerously low platelet counts and require platelet transfusions to prevent bleeding. However, we have found that platelets leak substances during blood bank storage that can mediate adverse inflammatory reactions when transfused. We are attempting to understand what causes this leakage and how to prevent it.
We also have recently been investigating the use of genetic testing to better predict correct doses of anticoagulant and anti-platelet drugs. Our initial focus has been on determining the advantages and disadvantages of different testing methods.
Specialized Terms: Blood group alloimmunization; Pharmacogenetics; Blood bank storage of platelets; Pro-inflammatory cytokines; Blood transfusion
Extensive Research Description
We have investigated the role of pro-inflammatory cytokines in mediating adverse effects of blood transfusion. We have shown that leukocyte-derived cytokines such as interleukins-1, -6, - 8, as well as MIP-1 alpha, GRO-alpha, and TNF-alpha are present in the plasma portion of stored platelet concentrates and are generated in vitro during blood bank preparation and storage. Some cytokines were also detected in the supernatant portion of red blood cell units. These cytokines are generated in direct proportion to the leukocyte content of the component, the storage temperature, and the storage time. Bacterial contamination of blood components, as might occur in the setting of a septic transfusion reaction, further stimulates cytokine generation. Pre-storage leukoreduction of blood components prevents the generation of leukocyte-dereived cytokines.
Research Interests
Blood Banks; Blood Transfusion; Pathology; Pharmacogenetics; Medical Laboratory Science; Cytokines
Education & Training
Fellow
Yale-New Haven Hospital (1991)
Resident
Yale-New Haven Hospital (1990)
Fellow
Institut de Chimie Bioligique (1987)
MD
Johns Hopkins University (1984)
PhD
University of Wisconsin (1983)
BS
University of Maryland-College Park, Biochemistry (1975)
Departments & Organizations
Blood BankLaboratory MedicineLaboratory Medicine - EducationOffice of Cooperative ResearchTransfusion Medicine ProgramVA Connecticut Clinical LaboratoriesYale University
研究兴趣
论文共 88 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
American journal of infection control (2024)
Transfusionno. 7 (2023): 1399-1411
Research Square (Research Square) (2022)
引用0浏览0引用
0
0
Research Square (Research Square) (2022)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn